Detalhe da pesquisa
1.
Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis.
N Engl J Med
; 385(15): 1372-1381, 2021 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614330
2.
Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC): a multicentre randomised controlled trial.
Lancet
; 396(10245): 167-176, 2020 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32682482
3.
Pancreatic exocrine insufficiency following acute pancreatitis: Systematic review and study level meta-analysis.
Pancreatology
; 18(3): 253-262, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29482892
4.
Acute pancreatitis: recent advances through randomised trials.
Gut
; 66(11): 2024-2032, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838972
5.
High-resolution anoscopy: clinical features of anal intraepithelial neoplasia in HIV-positive men.
Dis Colon Rectum
; 56(11): 1237-42, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24104998
6.
Predictors for choledocholithiasis in patients undergoing endoscopic ultrasound.
Scand J Gastroenterol
; 53(8): 984-985, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29979088
7.
Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Lancet Gastroenterol Hepatol
; 6(5): 350-358, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740415
8.
Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.
Trials
; 19(1): 207, 2018 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29606135
9.
Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial.
Trials
; 17: 5, 2016 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26729193